Immune Reconstitution Inflammatory Syndrome
Information
- Disease name
- Immune Reconstitution Inflammatory Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00286767 | Completed | Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy | February 1, 2006 | November 1, 2018 | |
| NCT01557803 | Completed | Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome | January 2012 | January 2015 | |
| NCT01924286 | Completed | Phase 3 | Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone | August 30, 2013 | April 2017 |
| NCT02063880 | Completed | N/A | Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART) | March 2013 | November 2015 |
| NCT02147405 | Recruiting | PET Imaging and Lymph Node Assessment of IRIS in People With AIDS | May 30, 2014 | December 31, 2026 | |
| NCT01211665 | Terminated | Phase 4 | Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) | September 2010 | February 2012 |
| NCT00988780 | Unknown status | N/A | Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients | December 2009 | April 2013 |
| NCT01442428 | Withdrawn | Phase 2/Phase 3 | Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial | January 2014 | June 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D054019